News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
712,737 Results
Type
Article (43480)
Company Profile (347)
Press Release (668910)
Section
Business (212005)
Career Advice (2167)
Deals (37034)
Drug Delivery (103)
Drug Development (83940)
Employer Resources (173)
FDA (16612)
Job Trends (15531)
News (359232)
Policy (34336)
Tag
Academia (2608)
Alliances (51725)
Alzheimer's disease (1258)
Approvals (16532)
Artificial intelligence (145)
Bankruptcy (368)
Best Places to Work (11740)
Biotechnology (221)
Breast cancer (123)
Cancer (1124)
Cardiovascular disease (105)
Career advice (1804)
Cell therapy (243)
Clinical research (66674)
Collaboration (404)
Compensation (202)
COVID-19 (2625)
C-suite (97)
Data (1134)
Diabetes (162)
Diagnostics (6255)
Drug pricing (96)
Earnings (86938)
Employer resources (152)
Events (113520)
Executive appointments (319)
FDA (17158)
Funding (360)
Gene therapy (191)
GLP-1 (646)
Government (4514)
Healthcare (18998)
Infectious disease (2716)
Inflammatory bowel disease (112)
Interviews (337)
IPO (16732)
Job creations (4157)
Job search strategy (1550)
Layoffs (449)
Legal (8464)
Lung cancer (179)
Manufacturing (190)
Medical device (13310)
Medtech (13315)
Mergers & acquisitions (20367)
Metabolic disorders (452)
Neuroscience (1549)
NextGen Class of 2024 (6714)
Non-profit (4539)
Northern California (1488)
Obesity (263)
Opinion (222)
Patents (109)
People (58750)
Pharmaceutical (101)
Phase I (20723)
Phase II (29306)
Phase III (21956)
Pipeline (459)
Postmarket research (2673)
Preclinical (8774)
Radiopharmaceuticals (245)
Rare diseases (233)
Real estate (6349)
Regulatory (22696)
Research institute (2382)
Resumes & cover letters (370)
Southern California (1306)
Startups (3780)
United States (13714)
Vaccines (579)
Weight loss (209)
Date
Today (136)
Last 7 days (772)
Last 30 days (3844)
Last 365 days (36573)
2024 (33549)
2023 (40928)
2022 (52113)
2021 (56678)
2020 (55112)
2019 (47824)
2018 (36141)
2017 (33572)
2016 (33169)
2015 (39008)
2014 (32962)
2013 (28077)
2012 (30166)
2011 (30873)
2010 (28890)
Location
Africa (804)
Arizona (201)
Asia (40963)
Australia (6498)
California (3359)
Canada (1299)
China (254)
Colorado (147)
Connecticut (156)
Europe (87628)
Florida (464)
Georgia (116)
Illinois (352)
Indiana (207)
Maryland (587)
Massachusetts (2658)
Michigan (158)
Minnesota (274)
New Jersey (971)
New York (962)
North Carolina (746)
Northern California (1488)
Ohio (142)
Pennsylvania (848)
South America (1179)
Southern California (1306)
Texas (474)
Washington State (369)
712,737 Results for "cmp pharma inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Bio NC
CMP Pharma, Inc Announces that Atorvaliq®, the First and Only FDA-approved Liquid Suspension of Atorvastatin is Now Available
CMP Pharma, Inc. announced today that Atorvaliq (atorvastatin calcium) Oral Suspension, 20 mg/5 mL, the first and only FDA-approved oral liquid of atorvastatin, is now available.
June 23, 2023
·
4 min read
Pharm Country
CMP Scientific Launches BioSummit™ CVA System, the Next-Generation cIEF-MS Platform for Charge Variant Analysis
CMP Scientific, a leader in capillary electrophoresis-mass spectrometry technologies, is proud to announce the launch of its highly anticipated BioSummit™ CVA system at the 72nd ASMS Conference on Mass Spectrometry and Allied Topics.
June 3, 2024
·
3 min read
Bio NC
CMP Pharma, Inc Announces that Liqrev®, the First and Only Ready-made FDA-approved Liquid Suspension of Sildenafil is Now Available
CMP Pharma, Inc. announced today that Liqrev (Sildenafil) Oral Suspension, 10 mg/mL, the first and only FDA-approved ready-made oral liquid of sildenafil, is now available.
June 21, 2023
·
5 min read
Press Releases
CAMP4 Therapeutics Secures Orphan Drug Designation for CMP-CPS-001 for the Treatment of Urea Cycle Disorders
September 18, 2024
·
2 min read
Genetown
CAMP4 Therapeutics Announces Dosing of First Participant in Phase 1 Clinical Study of CMP-CPS-001
CAMP4 Therapeutics Corp. today announced that the first participant has been dosed in the company’s Phase 1 clinical study of CMP-CPS-001, a potential first-in-class therapeutic for the treatment of urea cycle disorders (UCDs).
March 21, 2024
·
3 min read
Business
Astellas Pharma Opens Cambridge Life Sciences Center Featuring Incubator Space
Astellas Pharma’s new life sciences center houses its first U.S.-based SakuLab, an incubator space for external partners, as well as its engineered small molecules unit.
September 6, 2024
·
1 min read
·
Angela Gabriel
Editorial
Pharma’s Q3 Was a Rollercoaster Ride. Let’s Do It Again Next Quarter
Big Pharma had plenty of drama to keep journalists busy this quarter, which painted an accurate portrait of the wild and wonderful world of biopharma.
November 15, 2024
·
3 min read
·
Annalee Armstrong
Press Releases
Meiji Seika Pharma Announces Investment in ARCALIS, Inc.
November 14, 2024
·
3 min read
Press Releases
CAMP4 Therapeutics Secures Rare Pediatric Disease Designation for CMP-CPS-001 for the Treatment of Urea Cycle Disorders
August 27, 2024
·
3 min read
Bio NC
CMP Pharma’s Potassium Phosphates Injection Receives FDA Shelf Life Extension for Specific Lots
CMP Pharma announced today that in order to mitigate drug shortage concerns, the FDA’s CDER Office of Compliance has granted a shelf life extension for CMP Development LLC Potassium Phosphates Injection (NDA 212121).
March 31, 2023
·
4 min read
1 of 71,274
Next
